Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mayumi Ueyama"'
Autor:
Takako Watanabe, Sei Kakinuma, Mina Nakagawa, Kei Kiyohashi, Mamoru Watanabe, Mayumi Ueyama, Miyako Murakawa, Seishin Azuma, Naoya Sakamoto, Yuki Nishimura-Sakurai, Sayuri Nitta, Kiichiro Tsuchiya, Yasuhiro Itsui, Yusuke Funaoka, Shinya Oooka, Akiko Kitazume
Publikováno v:
Antimicrobial Agents and Chemotherapy. 55:2537-2545
A lack of patient response to alpha interferon (α-IFN) plus ribavirin (RBV) treatment is a major problem in eliminating hepatitis C virus (HCV). We screened chemical libraries for compounds that enhanced cellular responses to α-IFN and identified a
Autor:
Takako Watanabe, Akihide Kamiya, Naoya Sakamoto, Naohiko Koshikawa, Izumi Onozuka, Hiromitsu Nakauchi, Mayumi Ueyama, Mina Nakagawa, Yusuke Funaoka, Masato Miyoshi, Mamoru Watanabe, Kei Kiyohashi, Motoharu Seiki, Sei Kakinuma
Publikováno v:
Biochemical and Biophysical Research Communications. 406:134-140
Matrix metalloproteinase (MMP) plays an important role in homeostatic regulation of the extracellular environment and degradation of matrix. During liver fibrosis, several MMPs, including MMP-2, are up-regulated in activated hepatic stellate cells, w
Autor:
Mamoru Watanabe, Mayumi Ueyama, Masashi Mizokami, Eiji Tanaka, Yasuhito Tanaka, Katsushi Tokunaga, Akihiro Tamori, Masayuki Kurosaki, Mina Nakagawa, Nao Nishida, Yoichi Hiasa, Yasuhiro Itsui, Seishin Azuma, Yuko Sekine-Osajima, Shuhei Hige, Sei Kakinuma, Naoya Sakamoto, Nishimura-Sakurai Yuki, Namiki Izumi, Yoshito Itoh
Publikováno v:
Journal of Medical Virology. 83:871-878
Genetic polymorphisms of the interleukin 28B (IL28B) locus are associated closely with outcomes of pegylated-interferon (PEG-IFN) plus ribavirin (RBV) combination therapy. The aim of this study was to investigate the relationship between IL28B polymo
Autor:
Mina Nakagawa, Takako Watanabe, Satoshi Nagaie, Hiroshi Tanaka, Yuko Onuki-Karakama, Yuki Nishimura-Sakurai, Yusuke Funaoka, Nobuyuki Enomoto, Machi Yamamoto, Mamoru Watanabe, Megumi Tasaka-Fujita, Kako Mishima, Seishin Azuma, Yasuhiro Itsui, Yuko Sekine-Osajima, Kaoru Mogushi, Kiichiro Tsuchiya, Naoya Sakamoto, Sei Kakinuma, Goki Suda, Mayumi Ueyama
Publikováno v:
Journal of Gastroenterology. 45:523-536
Hepatitis C virus (HCV) replication is affected by several host factors. Here, we screened host genes and molecular pathways that are involved in HCV replication by comprehensive analyses using two genotypes of HCV replicon-expressing cells, their cu
Autor:
Mamoru Watanabe, Takako Watanabe, Kei Kiyohashi, Yuko Sekine-Osajima, Sayuri Nitta, Seishin Azuma, Yuki Nishimura-Sakurai, Yusuke Funaoka, Sei Kakinuma, Yasuhiro Itsui, Akiko Kitazume, Naoya Sakamoto, Mina Nakagawa, Miyako Murakawa, Mayumi Ueyama, Izumi Onozuka
Publikováno v:
Antiviral therapy. 16(7)
Background Interleukin (IL)-6, a pleiotropic cytokine, is increased in various types of chronic liver disease, including chronic hepatitis C (CHC). It was reported recently that IL-6 is associated with insulin resistance, iron metabolism and interfer
Autor:
Takako Watanabe, Mamoru Watanabe, Naoya Sakamoto, Mayumi Ueyama, Kako Mishima, Sayuri Nitta, Kiichiro Tsuchiya, Yusuke Funaoka, Mina Nakagawa, Goki Suda, Kei Kiyohashi, Seishin Azuma, Miyako Murakawa, Izumi Onozuka, Akiko Kitazume, Sei Kakinuma, Yasuhiro Itsui
Substitution of amino acids 70 and 91 in the hepatitis C virus (HCV) core region is a significant predictor of poor responses to peginterferon-plus-ribavirin therapy, while their molecular mechanisms remain unclear. Here we investigated these differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e16e4335be962f87f1edbbaf1b318685
https://europepmc.org/articles/PMC3126319/
https://europepmc.org/articles/PMC3126319/
Autor:
Machi Yamamoto, Mina Nakagawa, Takako Watanabe, Naoya Sakamoto, Sei Kakinuma, Yasuhiro Itsui, Yuko Karakama, Megumi Tasaka-Fujita, Seishin Azuma, Mayumi Ueyama, Yuki Nishimura-Sakurai, Yusuke Funaoka, Mamoru Watanabe, Kako Mishima, Gouki Suda, Yuko Sekine-Osajima
Publikováno v:
Hepatology (Baltimore, Md.). 50(6)
Interferons (IFNs) and the interferon-stimulated genes (ISGs) play a central role in antiviral responses against hepatitis C virus (HCV) infection. We have reported previously that ISGs, including guanylate binding protein 1 (GBP-1), interferon alpha
Autor:
Nobuyuki Enomoto, Kaoru Mogushi, Sei Kakinuma, Mina Nakagawa, Naoya Sakamoto, Mayumi Ueyama, Hiroshi Tanaka, Seishin Azuma, Mamoru Watanabe, Satoshi Nagaie, Yasuhiro Itsui
Publikováno v:
Journal of gastroenterology. 45(6)
Pegylated-interferon-alpha 2b (PEG-IFN) plus ribavirin (RBV) therapy is currently the de-facto standard treatment for hepatitis C virus (HCV) infection. The aims of this study were to analyze the clinical and virological factors associated with a hig